WHO-GMP Certified Commercial Pack · Product Code: AKP-079
Oxymetazoline HCl 0.025% w/v Nasal Spray
Formulation Overview: Long-acting 12-hour paediatric decongestant nasal solution offering gentle sustained mucosal shrinkage with minimal reactive hyperemia. Formulated with Oxymetazoline Hydrochloride IP 0.025% w/v (0.025% w/v) in Paediatric Nasal Decongestant Spray dosage form under Respiratory & Allergy, manufactured to IP / BP / USP Compendial standards and supplied in 10 ml Squeeze / Metered Nasal Spray Bottle with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-079 |
|---|---|
| Therapeutic Sector | Respiratory & Allergy |
| Dosage Form | Paediatric Nasal Decongestant Spray |
| Active Ingredient | Oxymetazoline Hydrochloride IP 0.025% w/v |
| Strength / Purity | 0.025% w/v |
| Clinical Indication | Childhood nasal congestion in upper respiratory viral infections and sinusitis |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 ml Squeeze / Metered Nasal Spray Bottle |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from direct light |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |